Mondi, Mary Joy S.
HRN: 21-84-57 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/28/2022
CEFTRIAXONE 1G (VIAL)
08/28/2022
09/03/2022
IV
2g
OD
Infectious Diarrhea, UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes